TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) Shareholders equity

annual shareholders equity:

$224.53M+$27.55M(+13.98%)
December 31, 2024

Summary

  • As of today (September 15, 2025), TARS annual stockholders equity is $224.53 million, with the most recent change of +$27.55 million (+13.98%) on December 31, 2024.
  • During the last 3 years, TARS annual shareholders equity has risen by +$57.80 million (+34.67%).
  • TARS annual shareholders equity is now at all-time high.

Performance

TARS Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly shareholders equity:

$332.61M-$9.85M(-2.88%)
June 30, 2025

Summary

  • As of today (September 15, 2025), TARS quarterly stockholders equity is $332.61 million, with the most recent change of -$9.85 million (-2.88%) on June 30, 2025.
  • Over the past year, TARS quarterly shareholders equity has increased by +$80.37 million (+31.86%).
  • TARS quarterly shareholders equity is now -2.88% below its all-time high of $342.46 million, reached on March 31, 2025.

Performance

TARS quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TARS Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.0%+31.9%
3 y3 years+34.7%+50.2%
5 y5 years+291.2%+535.2%

TARS Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+34.7%-2.9%+125.2%
5 y5-yearat high+291.2%-2.9%+535.2%
alltimeall timeat high>+9999.0%-2.9%+5638.9%

TARS Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$332.61M(-2.9%)
Mar 2025
-
$342.46M(+52.5%)
Dec 2024
$224.53M(+14.0%)
$224.53M(-5.5%)
Sep 2024
-
$237.48M(-5.9%)
Jun 2024
-
$252.25M(-8.3%)
Mar 2024
-
$275.21M(+39.7%)
Dec 2023
$196.99M(+2.1%)
$196.99M(-7.8%)
Sep 2023
-
$213.66M(+44.6%)
Jun 2023
-
$147.73M(-14.8%)
Mar 2023
-
$173.40M(-10.1%)
Dec 2022
$192.90M
$192.90M(-4.8%)
DateAnnualQuarterly
Sep 2022
-
$202.63M(-8.5%)
Jun 2022
-
$221.50M(+48.5%)
Mar 2022
-
$149.20M(-10.5%)
Dec 2021
$166.73M(+0.5%)
$166.73M(-6.9%)
Sep 2021
-
$179.14M(-6.9%)
Jun 2021
-
$192.47M(+5.0%)
Mar 2021
-
$183.23M(+10.4%)
Dec 2020
$165.98M(+189.2%)
$165.98M(+94.5%)
Sep 2020
-
$85.33M(+62.9%)
Jun 2020
-
$52.37M(-972.1%)
Dec 2019
$57.40M(+2497.1%)
-$6.00M
Dec 2018
$2.21M
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of TARS is $224.53M

What is the all time high annual shareholders equity for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual stockholders equity is $224.53M

What is Tarsus Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, TARS annual stockholders equity has changed by +$27.55M (+13.98%)

What is Tarsus Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of TARS is $332.61M

What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $342.46M

What is Tarsus Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, TARS quarterly stockholders equity has changed by +$80.37M (+31.86%)
On this page